CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $248,524 | -41.4% | 23,140 | -48.9% | 0.00% | -100.0% |
| Q3 2022 | $424,000 | +114.1% | 45,277 | +109.2% | 0.00% | – |
| Q2 2022 | $198,000 | -70.9% | 21,639 | -61.3% | 0.00% | -100.0% |
| Q1 2022 | $680,000 | +99.4% | 55,929 | +153.2% | 0.00% | – |
| Q3 2021 | $341,000 | -78.3% | 22,088 | -80.0% | 0.00% | -100.0% |
| Q2 2021 | $1,573,000 | -74.5% | 110,246 | -61.2% | 0.00% | -83.3% |
| Q1 2021 | $6,166,000 | +146.3% | 284,009 | +71.7% | 0.01% | +200.0% |
| Q4 2020 | $2,503,000 | +7.7% | 165,408 | -9.4% | 0.00% | 0.0% |
| Q3 2020 | $2,323,000 | -63.7% | 182,537 | -51.3% | 0.00% | -75.0% |
| Q2 2020 | $6,407,000 | -2.5% | 374,689 | -24.7% | 0.01% | -20.0% |
| Q1 2020 | $6,574,000 | +62.6% | 497,682 | +98.3% | 0.01% | +100.0% |
| Q4 2019 | $4,042,000 | +69.2% | 250,946 | +92.0% | 0.01% | +66.7% |
| Q3 2019 | $2,389,000 | +154.7% | 130,700 | +199.6% | 0.00% | +200.0% |
| Q2 2019 | $938,000 | -13.6% | 43,623 | -3.8% | 0.00% | 0.0% |
| Q3 2018 | $1,086,000 | +755.1% | 45,346 | +338.3% | 0.00% | – |
| Q4 2017 | $127,000 | -26.2% | 10,345 | -17.5% | 0.00% | – |
| Q3 2017 | $172,000 | -44.5% | 12,543 | -37.6% | 0.00% | -100.0% |
| Q2 2017 | $310,000 | -33.3% | 20,112 | -20.5% | 0.00% | 0.0% |
| Q1 2017 | $465,000 | +27.4% | 25,300 | -35.7% | 0.00% | 0.0% |
| Q4 2016 | $365,000 | +305.6% | 39,340 | +109.6% | 0.00% | – |
| Q2 2016 | $90,000 | -40.8% | 18,773 | -23.1% | 0.00% | – |
| Q1 2016 | $152,000 | -92.3% | 24,420 | -79.1% | 0.00% | -100.0% |
| Q4 2015 | $1,966,000 | -18.7% | 116,604 | -31.1% | 0.00% | -25.0% |
| Q3 2015 | $2,417,000 | +890.6% | 169,148 | +742.5% | 0.00% | – |
| Q2 2015 | $244,000 | +23.9% | 20,077 | +2.4% | 0.00% | – |
| Q1 2015 | $197,000 | +32.2% | 19,604 | +31.3% | 0.00% | – |
| Q4 2014 | $149,000 | – | 14,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |